Here we characterize Francisella tularensis live vaccine strain (LVS) infection in total tumor necrosis factor (TNF) knockout (KO) mice and in transgenic mice expressing only the membrane form of TNF (memTNF). MemTNF mice, but not TNF KO mice, survived low-dose, sublethal LVS infections. Splenic nitric oxide production was impaired in infected memTNF mice and was absent in infected TNF KO mice. Spleen cell production of interferon-␥, RANTES, and monocyte chemotactic protein-1 was elevated in TNF KO mice, compared with that in WT mice, by days 4 -5 after infection, along with transiently increased numbers of CCR2 ؉ cells, whereas memTNF mice had an intermediate phenotype. By day 6 after infection, TNF KO mice, but not memTNF mice, exhibited massive apoptosis in spleens and livers, which shortly preceded their death. Thus, memTNF partially functions to regulate chemokine expression, cell recruitment, and nitric oxide production during primary LVS infection and protects against the induction of apoptosis observed in TNF KO mice.
Francisella tularensis is a facultative intracellular pathogen that causes tularemia, a lethal febrile disease, in humans [1] . Although natural tularemia is rare, there is renewed interest in F. tularensis because of its potential use as a biowarfare agent. The F. tularensis live vaccine strain (LVS) has been used as an investigational human vaccine, although its protective efficacy and the key mechanisms of immunity to tularemia remain only partially characterized. To better understand the LVS vaccine and to facilitate the development of new tularemia vaccines, it is important to define the basis of protective immunity to F. tularensis. Discoveries defining immunity to F. tularensis infection may be applied to other intracellular pathogens, such as Mycobacterium tuberculosis and Listeria monocytogenes [2] .
Treatments for several chronic inflammatory diseases involve the therapeutic use of tumor necrosis factor (TNF) inhibitors. Although these therapies are successful, they are also associated with a significantly increased incidence of granulomatous infections, including those with M. tuberculosis and L. monocytogenes [3, 4] . Similar to these other intracellular pathogens, immunity to LVS in mice is dependent on TNF production [5] . Two classes of TNF blockers exist and differentially bind 2 distinct forms of TNF: membrane TNF (memTNF) and soluble TNF (sTNF) [3, 6] . Thus, it is important to define the relative contributions of sTNF and memTNF to intracellular infections (such as those with F. tularensis) that are highly TNF dependent.
Recently, mice that express only memTNF were developed [7] . Here, we have taken advantage of this memTNF mouse model to investigate the relative roles played by sTNF and memTNF during primary infection with F. tularensis LVS. We show that, unlike total TNF knockout (KO) mice, memTNF mice survived and cleared a low-dose primary LVS infection. During the first few crucial days of infection, production of splenic inducible NO synthase (iNOS) was impaired in memTNF mice and was absent in TNF KO mice. On day 6 after infection, a massive apoptotic event was observed in the spleens and livers of TNF KO mice but not in those of memTNF mice. In the complete absence of TNF, LVS growth was uncontrolled and was accompanied by high levels of apoptosis that resulted in liver damage. These findings have significance for acute intracellular infections in individuals treated with TNF inhibitors that affect the function of both sTNF and memTNF.
METHODS

Bacteria.
F. tularensis LVS (ATCC29684) was grown and frozen as described elsewhere [8] .
Mice and infections. Specific pathogen-free male C57BL/6J mice were purchased from Jackson Laboratory. TNF KO and memTNF mice were obtained via a material transfer agreement with Schering-Plough BioPharma (formerly DNAX) and were bred at the Center for Biologics Research and Evaluation (CBER), US Food and Drug Administration (FDA). All procedures were performed according to approved protocols under Animal Care and Use Committee guidelines.
Ex vivo culture of spleen cells. Spleen cell suspensions were prepared as described elsewhere [9] . Splenocytes (2 ϫ 10 7 ) were cultured overnight in Dulbecco's modified Eagle medium in a humidified CO 2 incubator (6%) at 37°C, and su- Figure 1 . Survival and clearance of a low-dose primary intradermal Francisella tularensis live vaccine strain (LVS) infection by mice expressing only membrane tumor necrosis factor (memTNF). C57BL/6J wild-type (WT) mice, TNF knockout (KO) mice, and memTNF mice were administered either 1 ϫ 10 2 (A and B ) or 1 ϫ 10 5 (C-F) cfu of LVS intradermally. To determine bacterial burdens, the nos. of colony-forming units were assessed at the indicated time points in the spleen (A and C ) and liver (B) (4 mice per group). To assess the production of cytokines during primary LVS challenge, spleen cells were harvested from infected mice at the indicated time points and cultured overnight. Culture supernatants were harvested after 18 h and tested for levels of nitric oxide (NO) (D), interferon (IFN)-␥ (E), and interleukin (IL)-12(p40) (F). Data are shown as mean Ϯ SD values for triplicate mice. Asterisks (*) indicate P Ͻ .01 for the comparison with WT cultures (Student's t test). These data are representative of 3 experiments of similar design.
pernatants were collected for quantification of cytokine and nitrite levels.
Quantification of cytokines and NO. Culture supernatants were assayed for interferon (IFN)-␥, interleukin (IL)-12(p40), RANTES, and monocyte chemotactic protein (MCP)-1 by standard sandwich ELISAs, and NO was assayed by Griess reaction, as described elsewhere [9] . Limits of detection for IFN-␥, IL-12(p40), MCP-1, and RANTES ELISAs were all Ͻ100 pg/mL, and the limit for the Griess reaction was 1.5 mol of nitrite per milliliter.
Flow cytometry analyses. Single-cell suspensions were analyzed using a Becton Dickinson LSR II flow cytometer and FlowJo software (version 7.2.1; Tree Star), as described elsewhere [9] . The anti-murine CCR2 antibody (Ab; clone MC-21) was a gift from M. Mack (University of Regensburg, Germany) [10] .
Analysis of in vivo cell proliferation. LVS-infected mice were injected with 1 mg of bromodeoxyuridine (BrdU) intraperitoneally 1 day before spleen harvest. Single-cell suspensions were stained for BrdU using FastImmune anti-BrdU FITC with DNase, per the manufacturer's instructions (Becton Dickinson).
Assays for dead and apoptotic cells. Dead spleen cells were identified using the Molecular Probes Live/Dead Fixable Violet Dead Cell Stain Kit, per the manufacturer's instructions (Invitrogen). Apoptotic cells were identified by performing TUNEL reactions on spleen cells that had been fixed immediately after harvest, per the manufacturer's instructions (Promega).
In vivo iNOS inhibition. Mice were provided water containing 4% aminoguanidine (AG; Sigma) ad libitum 3 days before and throughout the first 21 days of an intradermal infection with 6 ϫ 10 2 cfu of LVS. Inhibition of NO production was confirmed by removing spleen cells from AG-treated WT mice during the peak of infection and quantifying nitrite levels in the supernatants of lysed spleen cell preparations.
Histological and immunohistochemical analyses. Spleens and livers were fixed in 2% paraformaldehyde, cryoprotected in 30% sucrose, and frozen in isopentane. Frozen tissues were embedded in OCT/Cryogel (Instrumedics), and serial sections (5-9 m) were prepared. Spleen sections were incubated with antibodies in PBS containing 1% bovine serum albumin and 0.05% Triton X-100. Antibodies included mouse anti-Francisella LPS IgG 2a monoclonal Ab (clone FB11; Research Diagnostics), goat anti-mouse IgG 2a -biotin Ab (Southern Biotech), streptavidinAlexa555 (Invitrogen), rabbit anti-mouse iNOS antiserum (Santa Cruz Biotech), donkey anti-rabbit-Cy2 Ab and goat antirat-Cy5 Ab (Jackson Immunoresearch), and rat anti-mouse CD11b Ab (Pharmingen). Quantification of colocalization was performed on a minimum of 5 random sections from each of 3 individual mice per experiment, using the pixel colocalization software Imajin (CBER, FDA).
Detection of reactive oxygen intermediates (ROIs). Singlecell spleen suspensions were preloaded with 10 mol/L carboxy-H 2 -dichlorodihydrofluorescein diacetate (Sigma) for 45 min at 37°C in a humidified CO 2 incubator (6%). Loaded cells were stimulated with PBS, hydrogen peroxide (positive control), or 5 ϫ 10 6 cfu of LVS with or without 10 L of LVS-immune mouse serum. Cells were then incubated for 60 min at 37°C in a humidified CO 2 incubator (6%), and fluorescence was read (excitation, 492-495 nm; emission, 517-527 nm).
Aspartate aminotransferase (AST) assays. Blood was harvested from naive LVS-infected mice on day 6 after infection, via tail vein nick. Frozen serum was then sent to the Department of Laboratory Medicine Clinical Chemistry Veterinary Services, National Institutes of Health (Bethesda, Maryland), for serum AST measurements.
RESULTS
Sufficiency of memTNF to control and clear a low-dose, sublethal LVS infection.
To ascertain whether memTNF contributes to resistance against primary LVS infection, memTNF mice (transgenic mice that express only the membrane form of TNF) were infected with a sublethal dose (1 ϫ 10 2 cfu) of LVS intradermally, and growth in the liver and spleen was compared with that in WT and total TNF KO mice. TNF KO mice died of LVS infection within 7 days of inoculation, exhibiting unrestricted growth in both organs (figure 1A and 1B). LVS growth in the organs of WT mice was evident until approximately day 7, after which LVS numbers steadily declined to undetectable levels by day 14. In memTNF mice, bacterial burdens significantly higher than those in WT mice were detected at several time points (fig- ure 1A and 1B). The susceptibility of the memTNF, TNF KO, and WT mice to graded intradermal doses of LVS is compared in table 1. As expected, WT mice died only after receipt of very high doses of LVS (Ͼ1 ϫ 10 6 cfu), whereas all doses were lethal for 100% of TNF KO mice. In contrast, memTNF mice were more resistant to LVS than TNF KO mice; most memTNF mice survived low challenge doses, and variable numbers died at higher doses. Loss of control of bacterial growth within the first 72 h of in vivo infection in TNF KO mice and its correlation with a defect in NO production. Mice were next administered an LVS dose (1 ϫ 10 5 cfu intradermally) that is sublethal for WT mice but lethal for the memTNF and TNF KO mice. LVS growth was significantly higher in the spleens of memTNF and TNF KO mice as early as days 3 and 4 after infection ( figure 1C) . Loss of control of bacterial growth correlated with reduced levels of NO production by spleen cells harvested from infected mice ( figure  1D ) and revealed a hierarchy of levels of NO production: WT Ͼ memTNF Ͼ TNF KO. Interestingly, although the levels of NO in memTNF and TNF KO mice were reduced, the levels of splenic IFN-␥ (but not IL-12) were significantly higher in memTNF and TNF KO mice than in WT mice by day 5 ( figure 1E and 1F) . memTNF mice exhibited intermediate overproduction of IFN-␥ compared with TNF KO and WT mice ( figure 1E ). The reduction in ex vivo NO production correlated with reduced levels of iNOS protein in the spleens of memTNF and TNF KO mice on day 4 after infection, as determined by immunohistochemistry ( figure 2A ). This coincided with reduced colocalization of LVS and iNOS staining: 20% of LVS-positive staining colocalized with iNOS staining in WT mice, whereas only ϳ10% and 5% colocalized in spleen sections from memTNF and TNF KO mice, respectively (figure 2B).
In contrast, production of ROIs by spleen cells derived from WT, TNF KO, and memTNF mice on days 2-4 after infection was not different, regardless of whether the cells were unstimulated or stimulated with live LVS in the presence or absence of LVS-immune sera (figure 2C; only day 4 is shown). Thus, reduced ROI production does not contribute to the extreme susceptibility of TNF KO mice to LVS infection.
Reduced survival of memTNF mice during LVS infection resulting from inhibition of NO production. We next investigated whether the reduced NO production by memTNF mice contributed to survival. WT, memTNF, and TNF KO mice were administered the iNOS inhibitor AG orally during a low-dose LVS intradermal infection. As seen in figure 2D , all TNF KO mice died of infection, with no significant difference in mean time to death between the AG-treated and untreated groups (8.6 [SD, 0.9] days and 8.8 [SD, 0.4] days, respectively). All untreated and AG-treated WT mice survived (although the AG-treated WT mice appeared visibly ill), and only 1 of 5 untreated memTNF mice died of infection. Interestingly, all AG-treated memTNF mice (9/9) died of infection, with a mean Ϯ SD time to death of 12.8 Ϯ 4.6 days, surviving significantly longer than AG-treated TNF KO mice (P ϭ .03). Thus, iNOS contributes to the increased survival of memTNF mice compared with TNF KO mice, although it is not the only memTNF-dependent mechanism that contributes to survival of LVS infection.
No defect in cell recruitment to the spleen observed in TNF KO mice during early LVS infection. TNF regulates the transcription of numerous chemokines [11, 12] . Thus, we were interested in determining whether TNF-deficient mice would exhibit a defect in chemokine production and cell recruitment. As shown in figure 3A and 3B, splenic production of MCP-1 and RANTES was significantly increased in TNF KO and memTNF mice by day 5 after infection, compared with that in WT mice. As observed for IFN-␥, overproduction of RANTES and MCP-1 was greatest in TNF KO mice and was intermediate in memTNF mice.
The increased levels of MCP-1 and RANTES could be the result of reduced cell numbers expressing their cognate chemokine receptors, CCR2 and CCR5. To determine whether there was a defect in cell recruitment, we analyzed the spleen cell populations present during the first 5 days of an intradermal infection with 1 ϫ 10 5 cfu of LVS. Significant differences in the numbers of cells between the WT and TNF-deficient mice were observed only on days 3 and 5 after infection ( (table 2) . In some (3/6) experiments, a significant decrease in the number of T cells was observed on day 5 after infection in the TNF KO and memTNF mice, compared with that in WT mice. Thus, there was no obvious defect in the expansion or recruitment of critical myeloid cell populations to the spleen during the first 5 days of infection, although impaired T cell recruitment was evident in some experiments by day 5. Up-regulation of apoptosis in the livers and spleens of TNF KO mice just before death. Since TNF can regulate cell death, we compared total viable spleen cell numbers of WT, memTNF, and TNF KO mice during an intradermal infection with 1 ϫ 10 5 cfu of LVS. As shown in figure 4A , the numbers of total viable spleen cells in the 3 mouse strains were not significantly different until day 6 after infection, when the numbers of viable spleen cells in only the TNF KO mice decreased precipitously. At this time, the TNF KO mice were obviously ill.
To determine whether this decrease involved a defect in cell proliferation in TNF KO mice, BrdU was used to measure the numbers of actively dividing spleen cells between days 5 and 6. Due to the lower viable spleen cell count in TNF KO mice, the total number of cells proliferating in the spleens of TNF KO mice was reduced, compared with that in WT mice (figure 4B, right panel). However, there were no obvious differences in the proportion of viable spleen cells undergoing proliferation ( figure  4B , left panel) on day 6 after infection. Thus, decreased cell proliferation is not responsible for the lower cell number in TNF KO mice, compared with that in WT and memTNF mice.
We next used flow cytometry to quantify spleen cell death on day 6 after infection. There was a significant decrease in the proportion of viable spleen cells in TNF KO mice, compared with that in WT and memTNF mice ( figure 4C ). This correlated with a significantly higher proportion of apoptotic cells in TNF KO NOTE. Spleen cells were first gated on singlets, and then all single cells positive for an individual marker were assessed. Nos. indicate all cells that were positive for a given marker and do not take into account the multiple costaining that occurs for some cell types. Values are based on results obtained from 3 individual mice and are expressed as the total no. of cells ϫ 10 6 per spleen Ϯ SE. Boldface type indicates a significantly different no. compared with that for WT mice at the same time point (P Ͻ .05, Student's t test). These data are representative of 3-6 separate experiments. mice ( figure 4D ). Apoptotic cells in the spleens of TNF KO mice approached 50%-60% of the total cells on day 6 after infection, compared with ϳ15%-25% of cells in WT and memTNF mice. In contrast, the proportions of apoptotic cells in the spleens of all strains were ϳ15%-20% on days 4 and 5 after infection (data not shown) and were not significantly different from each other. Thus, the increase in apoptosis in the spleens of TNF KO mice occurs only on day 6 after infection and shortly precedes death.
Similarly, TUNEL staining of liver sections taken from LVSinfected mice on day 6 after infection revealed visibly higher levels of apoptotic cells in TNF KO mice than in WT and memTNF mice (figure 5A). The increased liver cell apoptosis correlated with significantly higher levels of serum aspartate transaminase (AST) enzyme activity in the TNF KO mice, compared with that memTNF and WT mice, on day 6 after infection ( figure 5B ). This high level of hepatotoxicity likely contributed to the death of TNF KO mice.
DISCUSSION
The recently discovered biological activity of memTNF raises questions regarding its role in the defense against intracellular infections and the impact of therapies using TNF inhibitors. The purpose of the present study was to establish the differential requirements for sTNF and memTNF during innate primary F. tularensis LVS murine infection. The data presented here reveal that memTNF can mediate the survival of low-dose LVS infection in the absence of sTNF ( figure 1A and 1B and table 1) . However, at higher LVS doses, memTNF was not sufficient to promote survival (table 1) . MemTNF mediated many of the essential activities of sTNF, although less efficiently-NO production (figures 1D and 2), cell trafficking (table 2), chemokine regulation ( figure 3A and 3B) , and IFN-␥ production ( figure 1E ) were all dysregulated in LVS-infected memTNF mice relative to that in WT mice but were intermediate in their phenotype relative to that in total TNF KO mice. Here, we have also shown, for the first time, that the death of TNF KO mice was preceded by massive apoptosis in spleens and livers, an event that did not occur in the memTNF and WT mice (figures 4D and 5).
Although memTNF induced iNOS protein expression and NO production in the spleens of LVS-infected mice, it was clearly not as efficient as sTNF (figures 1D, 2A, and 2B). TNF plays a critical role in activating macrophages to control the intramacrophage growth of LVS. Similar to findings for Leishma- nia, Listeria, and Mycobacterium species [13] [14] [15] , the addition of neutralizing anti-TNF Abs to LVS-infected macrophages in vitro abolished the ability of IFN-␥ to induce NO production and control intracellular growth [16, 17] . Thus, the observed lack of control of LVS growth in memTNF and TNF KO mice is likely due, at least in part, to the defect in NO production detected in these mice, compared with that in WT mice. Previous studies have shown both reduced and normal levels of iNOS activity in the spleens of memTNF mice given a primary intravenous BCG infection [18, 19] . iNOS expression in the lungs of mice infected aerogenically with M. tuberculosis was reduced, compared with that in WT mice [19] . Conversely, other studies have demonstrated overproduction of iNOS mRNA in the livers of memTNF mice during primary Listeria infection [20] .
Although low NO production in memTNF and TNF KO mice contributes to their susceptibility to LVS infection, it is not likely to completely explain the extreme vulnerability of TNF KO mice to LVS infection. iNOS KO mice survive moderate LVS doses (2 ϫ 10 3 cfu intradermally) for Ͼ3 weeks [21] , as do LVSinfected WT mice treated with AG ( figure 2D ), whereas TNF KO mice die after receipt of lower doses (ϳ1 ϫ 10 1 cfu intradermally) within 10 days (table 1) . Thus, there are additional defects in the TNF KO mice beyond diminished NO production. Interestingly, memTNF mice treated with AG survived significantly longer than did AG-treated TNF KO mice, suggesting that memTNF contributes to survival via multiple mechanisms (figure 2D) .
TNF regulates transcription of the gene for MCP-1 [11] , which recruits monocytes and macrophages to areas of inflammation. TNF also regulates expression of the gene for RANTES [12] , a ligand for CCR5 that is instrumental in recruiting naive T cells to antigen-expressing dendritic cells [22] . The known functions of both of these chemokines and their ligands suggest that they might contribute to the survival of an intracellular infection [23] [24] [25] [26] . Here, the loss of sTNF resulted in the overproduction of MCP-1 and RANTES in the spleens of memTNF and TNF KO mice during LVS infection ( figure 3A and 3B) . Similarly, levels of chemokine mRNAs were higher in Listeria-infected livers (CXCL1, CCL4, and CCL3) [20] and Mycobacterium-infected lungs (CXCL10, CCL7, and CCL5) [27] in TNF-deficient mice. Thus, similar to M. tuberculosis and L. monocytogenes infection, TNF and memTNF regulate chemokine expression in F. tularensis LVS infection. Whether the increased chemokine expression is directly due to gene regulation by TNF and memTNF, or whether such changes are a by-product of increased bacterial load, remains to be determined.
The total number of spleen cells expressing CCR2 in memTNF and TNF KO mice was transiently increased on day 3 after infection (table 2) . In contrast, the numbers of CD4 ϩ and CD8 ϩ T cells were significantly diminished on day 5. A similar result was observed in L. monocytogenes-infected memTNF mice, in which significantly lower numbers of CD4 ϩ and CD8 ϩ T cells were transiently seen in livers [20] . Because total T celldeficient mice survive an intradermal dose of 1 ϫ 10 5 cfu of LVS for more than a month before dying of the infection [28] , the diminished recruitment of T cells alone is not likely to significantly affect survival during early LVS infection. Notably, LVS growth remained uncontrolled in the TNF KO mice despite increased numbers of putative effector cells, such as the CD11b ϩ and Gr1 ϩ cells of the monocyte/neutrophil lineage.
We observed a significant drop in splenocyte viability in the TNF KO mice on day 6 after infection ( figure 4A ). This defect was not a result of diminished cell proliferation (figure 4B) and correlated with a massive apoptotic event in the spleens and livers of the TNF KO mice that was not observed in the memTNF and WT mice (figures 4D and 5A). This was accompanied by an increased serum AST level, a measure of hepatocellular damage ( figure 5A and 5B). The cause of this massive increase in apoptosis in TNF KO mice will be the subject of future studies. High LVS numbers in macrophages can induce apoptosis in vitro via a caspase 9 -dependent mechanism [29, 30] , and inflammasome activation is associated with high numbers of cytosolic bacteria, also resulting in apoptosis [31] . Indeed, the induction of apoptosis in TNF KO mice coincides with high bacterial burdens (1 ϫ 10 8 -1 ϫ 10 9 cfu of LVS per spleen or liver) and may be a direct consequence of uncontrolled LVS growth.
Taken together, we have shown here that memTNF can partially function to regulate chemokine expression, cell recruitment, and NO production during early innate responses to LVS infection. Furthermore, LVS growth is limited in memTNF mice, and memTNF protects against the enormous increase in apoptosis in liver and spleen cells that is observed in TNF KO mice. Thus, future studies of the roles of the 2 forms of TNF in infectious disease will be particularly important, given the differential abilities of some TNF inhibitors, such as infliximab, to bind to sTNF and memTNF.
